Organogenesis Switzerland GmbH
- Sector unverified
- Rank 314 / 334
Organogenesis Switzerland GmbH is recorded by Swissmedic as the authorisation holder for 1 human medicine, which places it 314 of 334 authorisation holders. Its portfolio is mostly in the Transplantat: Gewebeprodukt category (100 % of its authorisations). We hold no research of our own on this company's sector or business model, so we assign it to none.
Sector unverified: the Swissmedic list carries no sector field and we have not researched this company.
Key facts
| Sector | Not available |
|---|---|
| City | Not available |
| Canton | Not available |
| Authorisation holder | Yes |
| Medicines | 1 |
| Founded | Not available |
| Employees | Not available |
| Parent group | Not available |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
Organogenesis Switzerland GmbH is recorded by Swissmedic as the authorisation holder for 1 human medicine. The table shows 1 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
1 of 1 authorisation
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Apligaf Scheibe mit 75 mm Durchmesser (G100) | 58943 | A | - | 2015-04-16 |
Frequently asked questions
How many medicines does Organogenesis Switzerland GmbH have authorised in Switzerland?
Organogenesis Switzerland GmbH is recorded by Swissmedic as the authorisation holder for 1 human medicine (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Organogenesis Switzerland GmbH based?
We have no confirmed Swiss address for Organogenesis Switzerland GmbH. We add it as soon as the commercial register or the company confirms it.
Is Organogenesis Switzerland GmbH a Swissmedic authorisation holder?
Yes. Organogenesis Switzerland GmbH appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.